Semaglutide and the future of obesity care in the UK

E Fallows, L Ells, V Anand - The Lancet, 2023 - thelancet.com
The future of obesity care in the UK will partly be shaped by the National Institute for Health
and Care Excellence (NICE) endorsement of semaglutide (Wegovy) to treat obesity in …
被引用次数：7 相关文章

[引用][C] Semaglutide and the future of obesity care in the UK.

E Fallows, L Ells, V Anand - Lancet (London, England), 2023 - europepmc.org
Semaglutide and the future of obesity care in the UK. - Abstract - Europe PMC Sign in | Create
an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …

[引用][C] Semaglutide and the future of obesity care in the UK

E Fallows, L Ells, V Anand - Lancet, 2023 - eprints.leedsbeckett.ac.uk
Fallows, E and Ells, L and Anand, V (2023) Semaglutide and the future of obesity care in the
UK. Lancet, 401 (10394). pp. 2093-2096. ISSN 1474-547X DOI: https://doi …

[引用][C] Semaglutide and the future of obesity care in the UK

E Fallows, L Ells, V Anand - Lancet (London, England), 2023 - pubmed.ncbi.nlm.nih.gov